The CJEU’s decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. This report examines what we can already determine from the CJEU’s opinion and some implications that it may have depending on how EU member states and courts interpret the ruling.
No. of pages: 13
Photo: Guillaume Périgois